Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation TCT 2024

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

Presenter: Chun-Wei Lee

October 29, 2024

Presentation TCT 2024

TCT 811: Overweight and Obesity Have the Lowest Mortality Whereas Cachexia Has the Highest Inpatient Mortality Followed by Morbid Obesity in Patients Presenting With ST-Elevation Myocardial Infarction

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI

Presenter: Mohammad Reza Movahed

October 28, 2024

Presentation TCT 2024

Diabetes and Obesity: Modulating Cardiometabolic Risks

Presenter: C. Michael Gibson

October 28, 2024

Presentation TCT 2024

TCT 459: Lack of Obesity Paradox Regarding Mortality in Patients Undergoing Extracorporeal Membrane Oxygenation Treatment

Presenter: Mohammad Reza Movahed

October 27, 2024

Presentation ACC 2024

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Presenter: Jacob Eifer Møller

April 07, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation THT Abstracts 2024

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Presenter: Vivek Jha

March 04, 2024

Presentation THT 2024

Mechanisms and Therapeutic Targets for Obesity-Related HFpEF

Presenter: Jennifer Ho

March 04, 2024

Presentation THT 2024

The OBESITY-HF Connection: Time to Attack This Head-on

Presenter: Barry Borlaug

March 04, 2024

Presentation Controversies and Advances 2023

Obesity and Cardiovascular Disease

Presenter: Steven E. Nissen

November 30, 2023

Advertisement

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

TCT 811: Overweight and Obesity Have the Lowest Mortality Whereas Cachexia Has the Highest Inpatient Mortality Followed by Morbid Obesity in Patients Presenting With ST-Elevation Myocardial Infarction

TCT 243: Overweight Followed by Obesity and Morbid Obesity Have the Lowest Mortality, Whereas Cachexia Has the Highest Mortality Compared to Normal Weight Category in Patients Undergoing PCI

Diabetes and Obesity: Modulating Cardiometabolic Risks

TCT 459: Lack of Obesity Paradox Regarding Mortality in Patients Undergoing Extracorporeal Membrane Oxygenation Treatment

Percutaneous Transvalvular Micro axial Flow Pump in Infarct Related Cardiogenic Shock

Main Results From The Step-hfpef Dm Trial

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Mechanisms and Therapeutic Targets for Obesity-Related HFpEF

The OBESITY-HF Connection: Time to Attack This Head-on

Obesity and Cardiovascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content